TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 5 (6), 587-596
- https://doi.org/10.1016/j.ccr.2004.05.023
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- NF-κB activation in premalignant mouse tal-1/scl thymocytes and tumorsBlood, 2003
- Occurrence of leukaemia following gene therapy of X-linked SCIDNature Reviews Cancer, 2003
- Regulation of pTα Gene Expression by a Dosage of E2A, HEB, and SCLPublished by Elsevier ,2003
- The pTα promoter and enhancer are direct targets for transactivation by E box-binding proteinsEuropean Journal of Immunology, 2002
- Helix-Loop-Helix Proteins Regulate Pre-TCR and TCR Signaling through Modulation of Rel/NF-κB ActivitiesImmunity, 2002
- The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in miceOncogene, 2001
- Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCLNature, 1995
- RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangementCell, 1992
- Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line.Genes & Development, 1991
- Mouse T cell antigen receptor: Structure and organization of constant and joining gene segments encoding the β polypeptideCell, 1984